- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03812913
Neuropsychological Assessment of Children and Adolescents With Turner Syndrome (ENEAST)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cross-sectional study (2 groups : Turner syndrome, isolated growth hormone deficiency), not randomized, controlled, associating several specialized centers in endocrine diseases.
The pediatric endocrinologist of the participating centers will contact parents of each patient or voluntary child/adolescent in order to inform them of the study.
The visit of inclusion will take place in the participant center during a routine monitoring visit.
The first visit (V1) will take place immediately after the visit of inclusion in order to avoid a specific displacement for the needs for the study. The second visit (V2) will take place in participant's home. Each visit (V1 and V2) will last half-day. The period between V1 and V2 will be three months maximum.
The visits V1 and V2 will be carried out by neuropsychologists of the Laboratoire de Psychologie des Pays de la Loire (LPPL - EA 4638).
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Régis Coutant, MD PhD
- Phone Number: 33(02)41-35-56-55
- Email: ReCoutant@chu-angers.fr
Study Contact Backup
- Name: Emmanuel Quemener, CRA
- Phone Number: 33(02)41-35-45-81
- Email: EmQuemener@chu-angers.fr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
- 35 patients with Turner syndrome
- 35 patients with isolated growth hormone deficiency
Description
INCLUSION CRITERIA
Turner syndrome group :
- girls with diagnosed Turner syndrome.
Isolated GHD group :
- girls with diagnosed isolated growth hormone deficiency
All participants :
- age between 7 years to 16 years and 11 months.
- informed consent signed by the participant and her parents (or her legal representatives)
- being registered in the national social security system
EXCLUSION CRITERIA :
Turner syndrome group :
- patients with chronic pathology other than Turner syndrome.
- karyotype : part of a Y chromosome and r(X) cases.
- medical treatment other than those usually prescribed in patients with Turner syndrome.
Isolated GHD group :
- patients with chronic pathology other than isolated growth hormone deficiency.
- medical treatment other than those usually prescribed in patients with isolated growth hormone deficiency.
All participants :
- diagnosed intellectual disability (IQ<70) or intellectual giftedness
- history of acquired brain injury
- sensory disturbances (auditory or visual) incompatible with the achievement of neuropsychological tasks.
- insufficient French language proficiency
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Turner Syndrome
|
|
isolated GHD
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wechsler Intelligence Scale for Children (WISC-V)
Time Frame: 3 months
|
intelligence scale.
|
3 months
|
Cognitive theory of mind first order
Time Frame: 3 months
|
First order theory of mind tasks (Baron-Cohen et al., 1985)
|
3 months
|
Cognitive theory of mind second order
Time Frame: 3 months
|
second-order theory of mind tasks Perner & Wimmer, 1983)
|
3 months
|
Cognitive theory of mind advanced
Time Frame: 3 months
|
advanced theory of mind tasks (Happé, 1994)
|
3 months
|
Cognitive theory of mind : humor
Time Frame: 3 months
|
Humor understanding task
|
3 months
|
Affective theory of mind : faux pas
Time Frame: 3 months
|
Faux pas recognition test (Baron Cohen et al., 1999)
|
3 months
|
Affective theory of mind : first order
Time Frame: 3 months
|
First-order affective theory of mind tasks
|
3 months
|
Affective theory of mind : second order
Time Frame: 3 months
|
Second-order affective theory of mind tasks
|
3 months
|
Affective theory of mind : emotional inference
Time Frame: 3 months
|
Emotional inference for context test
|
3 months
|
Emotional valence recognition : valence
Time Frame: 3 months
|
Emotional valence rating from visual scenes
|
3 months
|
Facial emotion recogniton
Time Frame: 3 months
|
Facial emotion recognition task
|
3 months
|
Vocal emotion recognition
Time Frame: 3 months
|
Emotional prosody recognition task
|
3 months
|
Emotional regulation
Time Frame: 3 months
|
Emotion Regulation Questionnaire for Children and Adolescents (ERQ-CA)
|
3 months
|
Alexithymia
Time Frame: 3 months
|
Questionnaire d'alexithymie chez l'enfant (QAE)
|
3 months
|
Empathy
Time Frame: 3 months
|
Interpersonal Reactivity Index (IRI)
|
3 months
|
Oral Language comprehension abilities 1
Time Frame: 3 months
|
Comprehension of Instructions (NEPSY-II, Korkman et al., 2012)
|
3 months
|
Oral Language comprehension abilities 2
Time Frame: 3 months
|
Verbal comprehension index (from WISC-V)
|
3 months
|
Visual and visual-spatial abilities:1
Time Frame: 3 months
|
Arrows subtest (NEPSY-II - Korkman et al., 2012),
|
3 months
|
Visual and visual-spatial abilities:2
Time Frame: 3 months
|
Picture Puzzles subtest (NEPSY-II - Korkman et al., 2012)
|
3 months
|
Visual and visual-spatial abilities:3
Time Frame: 3 months
|
Benton Facial Recognition Test (Benton et al., 1983)
|
3 months
|
Executive abilities-Verbal Working memory 1
Time Frame: 3 months
|
Verbal information updating task
|
3 months
|
Executive abilities-Visuo-Spatial Working memory 2
Time Frame: 3 months
|
Visuo-spatial information updating task
|
3 months
|
Executive abilities-Inhibition 1
Time Frame: 3 months
|
Stroop test.
|
3 months
|
Executive abilities-Inhibition 2
Time Frame: 3 months
|
Tapping test
|
3 months
|
Executive abilities-Inhibition 3
Time Frame: 3 months
|
non-verbal cancellation task
|
3 months
|
Executive abilities-Cognitive Flexibility 1
Time Frame: 3 months
|
Verbal fluency task (NEPSY-II Korkman et al., 2012)
|
3 months
|
Executive abilities-Cognitive Flexibility 2
Time Frame: 3 months
|
Modified Wisconsin Card Sorting Test for children
|
3 months
|
Executive abilities-Cognitive Flexibility 3
Time Frame: 3 months
|
Trail Making Test
|
3 months
|
Executive abilities-Higher-order executive functions 1
Time Frame: 3 months
|
script generation task
|
3 months
|
Executive abilities-Higher-order executive functions 2
Time Frame: 3 months
|
Rey Complex Figure Test : Copy
|
3 months
|
Executive abilities in daily life
Time Frame: 3 months
|
Behavioral Rating Inventory of Executive Functions
|
3 months
|
Self Esteem
Time Frame: 3 months
|
Rosenberg self-esteem scale (1965).
|
3 months
|
Depression inventory
Time Frame: 3 months
|
Depression: Children's Depression Inventory (Kovacks & Beck, 1977).
|
3 months
|
Anxiety inventory
Time Frame: 3 months
|
Revised Children's Manifest Anxiety Scale (Reynolds & Richmond, 1999).
|
3 months
|
Social desirability
Time Frame: 3 months
|
Children's Social Desirability Scale (Crandall et al., 1965)
|
3 months
|
social adjustment 1
Time Frame: 3 months
|
Conners' Parent Rating Scale-Revised: Short Form (Conners, 1997)
|
3 months
|
social adjustment 2
Time Frame: 3 months
|
Conners' Teacher Rating Scale-Revised: Short Form (Conners, 1997)
|
3 months
|
behavioral adjustment
Time Frame: 3 months
|
Child Behavior Checklist (Achenbach, 1991).
|
3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Régis Coutant, MD PhD, UH Angers
Publications and helpful links
General Publications
- Baron-Cohen S, Leslie AM, Frith U. Does the autistic child have a "theory of mind"? Cognition. 1985 Oct;21(1):37-46. doi: 10.1016/0010-0277(85)90022-8. No abstract available.
- Gullone E, Taffe J. The Emotion Regulation Questionnaire for Children and Adolescents (ERQ-CA): a psychometric evaluation. Psychol Assess. 2012 Jun;24(2):409-17. doi: 10.1037/a0025777. Epub 2011 Oct 24.
- LoBue V, Thrasher C. The Child Affective Facial Expression (CAFE) set: validity and reliability from untrained adults. Front Psychol. 2015 Jan 6;5:1532. doi: 10.3389/fpsyg.2014.01532. eCollection 2014.
- Olszanowski M, Pochwatko G, Kuklinski K, Scibor-Rylski M, Lewinski P, Ohme RK. Warsaw set of emotional facial expression pictures: a validation study of facial display photographs. Front Psychol. 2015 Jan 5;5:1516. doi: 10.3389/fpsyg.2014.01516. eCollection 2014.
- Happe FG. An advanced test of theory of mind: understanding of story characters' thoughts and feelings by able autistic, mentally handicapped, and normal children and adults. J Autism Dev Disord. 1994 Apr;24(2):129-54. doi: 10.1007/BF02172093.
- Wimmer H, Perner J. Beliefs about beliefs: representation and constraining function of wrong beliefs in young children's understanding of deception. Cognition. 1983 Jan;13(1):103-28. doi: 10.1016/0010-0277(83)90004-5. No abstract available.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Endocrine System Diseases
- Disease
- Gonadal Disorders
- Disorders of Sex Development
- Urogenital Abnormalities
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Musculoskeletal Diseases
- Hypothalamic Diseases
- Bone Diseases
- Heart Defects, Congenital
- Cardiovascular Abnormalities
- Bone Diseases, Endocrine
- Pituitary Diseases
- Chromosome Disorders
- Dwarfism
- Bone Diseases, Developmental
- Hypopituitarism
- Sex Chromosome Disorders
- Sex Chromosome Disorders of Sex Development
- Syndrome
- Dwarfism, Pituitary
- Turner Syndrome
- Gonadal Dysgenesis
Other Study ID Numbers
- 2018-A01478-47
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Isolated Growth Hormone Deficiency
-
Rabin Medical CenterRecruitingGrowth Retardation | IGHD - Isolated Growth Hormone DeficiencyIsrael
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyFrance
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyDenmark
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyGermany
-
National Institute of Diabetes and Digestive and...Genentech, Inc.Completed
-
PfizerTerminatedGrowth Hormone DeficiencyGermany
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Growth Hormone Deficiency in ChildrenIsrael, Denmark, Belgium, Spain, Macedonia, The Former Yugoslav Republic of, Turkey, United Kingdom, France, Slovenia, Czech Republic
-
Novo Nordisk A/SWithdrawnGrowth Hormone Disorder | Growth Hormone Deficiency in Children
-
Novo Nordisk A/SCompletedHealthy | Growth Hormone Disorder | Adult Growth Hormone DeficiencyUnited States
-
Teva Pharmaceutical Industries, Ltd.TerminatedGrowth Hormone-DeficiencyBelarus, Bulgaria, Georgia, Greece, Hungary, Israel, Poland, Romania, Russian Federation, Serbia, Spain, Turkey, Ukraine
Clinical Trials on psychological evaluation
-
University Hospital, BordeauxRecruitingMultiple SclerosisFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingUterine Cervical NeoplasmsItaly
-
Parc de Salut MarUniversitat Autonoma de BarcelonaCompletedPsychotic Disorders | Stress, Psychological | Psychological Trauma | Cross-Cultural ComparisonSpain
-
University Hospital, BordeauxRoche Pharma AGRecruitingMultiple Sclerosis, Primary ProgressiveFrance
-
Fondation LenvalCompleted
-
University Hospital, AngersTerminated
-
Centre Hospitalier Universitaire de NiceCompletedEnd Stage Renal FailureFrance
-
University Hospital, BordeauxCompleted
-
St. Jude Children's Research HospitalAmerican Cancer Society, Inc.RecruitingSolid Tumor, Childhood | Brain Tumor, PediatricUnited States
-
Assistance Publique Hopitaux De MarseilleCompletedSevere Forms of Hemophilia | Other Constitutional Bleeding DisordersFrance